Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.
Clinical trial NCT01808885 · COMPLETED
Trial details
- NCT number
- NCT01808885
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-01-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.